ATGL activity regulates GLUT1-mediated glucose uptake and lactate production via TXNIP stability in adipocytes

被引:0
作者
Beg M. [1 ]
Zhang W. [1 ]
McCourt A.C. [1 ]
Enerbäck S. [1 ]
机构
[1] The Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg
关键词
Enzymes; -; Glucose;
D O I
10.1016/J.JBC.2021.100332
中图分类号
O62 [有机化学]; TQ [化学工业];
学科分类号
070303 ; 0817 ; 081704 ;
摘要
Traditionally, lipolysis has been regarded as an enzymatic activity that liberates fatty acids as metabolic fuel. However, recent work has shown that novel substrates, including a variety of lipid compounds such as fatty acids and their derivatives, release lipolysis products that act as signaling molecules and transcriptional modulators. While these studies have expanded the role of lipolysis, the mechanisms underpinning lipolysis signaling are not fully defined. Here, we uncover a new mechanism regulating glucose uptake, whereby activation of lipolysis, in response to elevated cAMP, leads to the stimulation of thioredoxin-interacting protein (TXNIP) degradation. This, in turn, selectively induces glucose transporter 1 surface localization and glucose uptake in 3T3-L1 adipocytes and increases lactate production. Interestingly, cAMP-induced glucose uptake via degradation of TXNIP is largely dependent upon adipose triglyceride lipase (ATGL) and not hormone-sensitive lipase or monoacylglycerol lipase. Pharmacological inhibition or knockdown of ATGL alone prevents cAMP-dependent TXNIP degradation and thus significantly decreases glucose uptake and lactate secretion. Conversely, overexpression of ATGL amplifies the cAMP response, yielding increased glucose uptake and lactate production. Similarly, knockdown of TXNIP elicits enhanced basal glucose uptake and lactate secretion, and increased cAMP further amplifies this phenotype. Overexpression of TXNIP reduces basal and cAMP-stimulated glucose uptake and lactate secretion. As a proof of concept, we replicated these findings in human primary adipocytes and observed TXNIP degradation and increased glucose uptake and lactate secretion upon elevated cAMP signaling. Taken together, our results suggest a crosstalk between ATGL-mediated lipolysis and glucose uptake. © 2021 American Society for Biochemistry and Molecular Biology Inc.. All rights reserved.
引用
收藏
相关论文
共 29 条
  • [11] Yore M. M., Syed I., Moraes-Vieira P. M., Zhang T., Herman M. A., Homan E. A., Patel R. T., Lee J., Chen S., Peroni O. D., Dhaneshwar A. S., Hammarstedt A., Smith U., McGraw T. E., Saghatelian A., Et al., Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects, Cell, 159, pp. 318-332, (2014)
  • [12] Nugent C., Prins J. B., Whitehead J. P., Wentworth J. M., Chatterjee V. K., O'Rahilly S., Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma, J. Biol. Chem, 276, pp. 9149-9157, (2001)
  • [13] Leto D., Saltiel A. R., Regulation of glucose transport by insulin: Traffic control of GLUT4, Nat. Rev. Mol. Cell Biol, 13, pp. 383-396, (2012)
  • [14] Klip A., McGraw T. E., James D. E., Thirty sweet years of GLUT4, J. Biol. Chem, 294, pp. 11369-11381, (2019)
  • [15] Waldhart A. N., Dykstra H., Peck A. S., Boguslawski E. A., Madaj Z. B., Wen J., Veldkamp K., Hollowell M., Zheng B., Cantley L. C., McGraw T. E., Wu N., Phosphorylation of TXNIP by AKT mediates acute influx of glucose in response to insulin, Cell Rep, 19, pp. 2005-2013, (2017)
  • [16] Wu N., Zheng B., Shaywitz A., Dagon Y., Tower C., Bellinger G., Shen C. H., Wen J., Asara J., McGraw T. E., Kahn B. B., Cantley L. C., AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1, Mol. Cell, 49, pp. 1167-1175, (2013)
  • [17] Haber E. P., Hirabara S. M., Gomes A. D., Curi R., Carpinelli A. R., Carvalho C. R., Palmitate modulates the early steps of insulin signalling pathway in pancreatic islets, FEBS Lett, 544, pp. 185-188, (2003)
  • [18] Schweiger M., Romauch M., Schreiber R., Grabner G. F., Hutter S., Kotzbeck P., Benedikt P., Eichmann T. O., Yamada S., Knittelfelder O., Diwoky C., Doler C., Mayer N., De Cecco W., Breinbauer R., Et al., Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice, Nat. Commun, 8, (2017)
  • [19] Carmen G. Y., Victor S. M., Signalling mechanisms regulating lipolysis, Cell Signal, 18, pp. 401-408, (2006)
  • [20] Mayer N., Schweiger M., Romauch M., Grabner G. F., Eichmann T. O., Fuchs E., Ivkovic J., Heier C., Mrak I., Lass A., Hofler G., Fledelius C., Zechner R., Zimmermann R., Breinbauer R., Development of small-molecule inhibitors targeting adipose triglyceride lipase, Nat. Chem. Biol, 9, pp. 785-787, (2013)